What indicates that the lesion is optimized in the DCB procedure?

• A. Visual confirmation of healing
• B. Regular follow-up assessments
• C. Results from reassessment with IVUS
• D. Effective patient feedback

Answer: (C)

In the context of a drug-coated balloon (DCB) procedure, the optimization of a lesion refers to the successful treatment and expected healing process following the intervention. The use of intravascular ultrasound (IVUS) is crucial for this assessment as it provides detailed visualization of the vascular structure and the status of the lesion after treatment.

Through IVUS, healthcare providers can evaluate the luminal diameter of the treated lesion, check for residual stenosis, and assess the overall vascular response to the DCB therapy. This advanced imaging technique allows for precise measurements and helps to confirm that the lesion has been adequately treated, ensuring that the balloon has delivered the therapeutic agent effectively to promote healing and prevent restenosis.

While visual confirmation, regular follow-up, and patient feedback are important aspects of post-procedure monitoring, they do not provide the same level of objective measurement as IVUS. These other methods may indicate patient progress or symptoms, but they lack the detailed anatomical and functional insights that IVUS offers regarding the optimization of the lesion specifically in response to DCB therapy.